| Dr Joseph Reed Toler, OD | |
|
9231 Amelia St, Amelia, VA 23002-0000 | |
| (804) 561-3937 | |
| Not Available |
| Full Name | Dr Joseph Reed Toler |
|---|---|
| Gender | Male |
| Speciality | Optometrist - Corneal And Contact Management |
| Location | 9231 Amelia St, Amelia, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366464109 | NPI | - | NPPES |
| 061293 | Other | VA | ANTHEM-BC/BS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152WC0802X | Optometrist - Corneal And Contact Management | 0618000415 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joseph Reed Toler, OD 5640 Riverside Dr, Richmond, VA 23225-2536 Ph: (804) 387-6918 | Dr Joseph Reed Toler, OD 9231 Amelia St, Amelia, VA 23002-0000 Ph: (804) 561-3937 |
News Archive
Nanogen announced today it was issued Patent No. 6,942,778, "Microstructure Apparatus and Method for Separating Differently Charged Molecules Using an Applied Electric Field" by the U.S. Patent and Trademark Office.
Inovalon, Inc., a leading provider of data-driven healthcare solutions, today announced that Allscripts and Inovalon have entered into a multi-year agreement that enables Inovalon's advanced healthcare data analytics for payers to leverage Allscripts Electronic Health Record (EHR) Platform to improve clinical and quality outcomes and financial performance.
ZymoGenetics, Inc. today reported substantially improved financial results for the quarter ended June 30, 2010. For the second quarter of 2010, the company's net loss declined to $3.8 million, or $0.04 per share, a $23.2 million improvement from the $27.0 million loss, or $0.39 per share, reported for the second quarter of 2009. The improvement resulted from higher revenues as well as reduced operating expenses.
More than 200,000 U.S. soldiers serving in the Middle East have experienced a blast-related traumatic brain injury, making it a common health problem and concern for that population.
Light chain amyloidosis, a deadly protein misfolding disease, is caused by multiple mutations in cells that are intended to protect the body. Instead, the mutations send misfolded bundles of proteins through the bloodstream, potentially destroying the heart, kidneys, liver or other organs. Mayo Clinic researchers have identified one of these mutations and have shown that the molecule's shifting position is as important as its unique shape. The findings appear in the current issue of the journal Structure.
› Verified 4 days ago